PRKCD and prostate carcinoma: Similar to our present experiment, in the study conducted by Kharait et al. (2006[21]), rottlerin reduced the migration and invasion of prostate cancer cells PC-3 (and also DU145); according to the authors of that study, the anticancer effects of rottlerin were caused by the inhibition of PKCδ expression.